HEADER CELL CYCLE 02-APR-21 7MCF TITLE CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX TITLE 2 WITH 2-{3-(1,4-DIMETHYL-1H-1,2,3-TRIAZOL-5-YL)-6-FLUORO-5-[(S)-(3- TITLE 3 FLUOROPYRIDIN-2-YL)(OXAN-4-YL)METHYL]-5H-PYRIDO[3,2-B]INDOL-7- TITLE 4 YL}PROPAN-2-OL COMPND MOL_ID: 1; COMPND 2 MOLECULE: BROMODOMAIN-CONTAINING PROTEIN 4; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: PROTEIN HUNK1; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BRD4, HUNK1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET28 KEYWDS BROMODOMAIN-CONTAINING PROTEIN 4 ISOFORM LONG, BRD4, BROMODOMAIN KEYWDS 2 CONTAINING PROTEIN 4, CAP, HUNK1, MCAP, MITOTIC CHROMOSOME KEYWDS 3 ASSOCIATED PROTEIN SGC, CELL CYCLE EXPDTA X-RAY DIFFRACTION AUTHOR S.SHERIFF REVDAT 3 18-OCT-23 7MCF 1 REMARK REVDAT 2 02-JUN-21 7MCF 1 JRNL REVDAT 1 26-MAY-21 7MCF 0 JRNL AUTH M.D.HILL,H.FANG,J.TOKARSKI,C.FANSLAU,Z.HAARHOFF,C.HUANG, JRNL AUTH 2 M.KRAMER,K.MENARD,L.MONEREAU,J.MORRISON,A.RANASINGHE, JRNL AUTH 3 E.E.SHIELDS,C.K.TYE,R.WESTHOUSE,G.EVERLOF,S.SHERIFF,C.YAN, JRNL AUTH 4 F.MARSILIO,L.ZHANG,T.ZVYAGA,F.LEE,A.V.GAVAI,A.P.DEGNAN JRNL TITL DEVELOPMENT OF BET INHIBITORS AS POTENTIAL TREATMENTS FOR JRNL TITL 2 CANCER: A SEARCH FOR STRUCTURAL DIVERSITY. JRNL REF BIOORG.MED.CHEM.LETT. V. 44 28108 2021 JRNL REFN ESSN 1464-3405 JRNL PMID 33991625 JRNL DOI 10.1016/J.BMCL.2021.128108 REMARK 2 REMARK 2 RESOLUTION. 2.19 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.6 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.19 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.89 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 15361 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.206 REMARK 3 R VALUE (WORKING SET) : 0.204 REMARK 3 FREE R VALUE : 0.234 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.620 REMARK 3 FREE R VALUE TEST SET COUNT : 709 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 8 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.19 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.34 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.66 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2673 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2035 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2540 REMARK 3 BIN R VALUE (WORKING SET) : 0.2003 REMARK 3 BIN FREE R VALUE : 0.2668 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.98 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 133 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1767 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 78 REMARK 3 SOLVENT ATOMS : 94 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 35.49 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 30.47 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.99700 REMARK 3 B22 (A**2) : 4.01950 REMARK 3 B33 (A**2) : -1.02250 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.310 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.237 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.184 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.229 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.181 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.924 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.908 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 1961 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 2737 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 643 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 56 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 341 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 1961 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 240 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2405 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.02 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.18 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 15.94 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7MCF COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 02-APR-21. REMARK 100 THE DEPOSITION ID IS D_1000255982. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 26-MAR-15 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 15428 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.190 REMARK 200 RESOLUTION RANGE LOW (A) : 43.960 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 5.900 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.08700 REMARK 200 FOR THE DATA SET : 14.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.19 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.68 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.7 REMARK 200 DATA REDUNDANCY IN SHELL : 5.60 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.30100 REMARK 200 FOR SHELL : 5.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3UVW REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.89 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.36 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM TRIS, PH 7.0, 100 MM NACL, REMARK 280 30%(W/V) PEG 3000, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 43.95600 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 44.67800 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 43.95600 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 44.67800 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 41 REMARK 465 HIS A 42 REMARK 465 MET A 43 REMARK 465 ASN A 44 REMARK 465 PRO A 45 REMARK 465 PRO A 46 REMARK 465 PRO A 47 REMARK 465 PRO A 48 REMARK 465 GLU A 49 REMARK 465 THR A 50 REMARK 465 SER A 51 REMARK 465 ASN A 52 REMARK 465 PRO A 53 REMARK 465 ASN A 54 REMARK 465 LYS A 55 REMARK 465 PRO A 56 REMARK 465 LYS A 57 REMARK 465 THR A 166 REMARK 465 GLU A 167 REMARK 465 GLU A 168 REMARK 465 GLY B 41 REMARK 465 HIS B 42 REMARK 465 MET B 43 REMARK 465 ASN B 44 REMARK 465 PRO B 45 REMARK 465 PRO B 46 REMARK 465 PRO B 47 REMARK 465 PRO B 48 REMARK 465 GLU B 49 REMARK 465 THR B 50 REMARK 465 SER B 51 REMARK 465 ASN B 52 REMARK 465 PRO B 53 REMARK 465 ASN B 54 REMARK 465 LYS B 55 REMARK 465 PRO B 56 REMARK 465 LYS B 57 REMARK 465 ARG B 58 REMARK 465 GLN B 59 REMARK 465 GLU B 168 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 58 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 76 CD CE NZ REMARK 470 LYS A 91 CE NZ REMARK 470 LYS A 112 CD CE NZ REMARK 470 TRP A 120 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP A 120 CZ3 CH2 REMARK 470 LYS A 141 CD CE NZ REMARK 470 GLU A 163 CG CD OE1 OE2 REMARK 470 LEU A 164 CG CD1 CD2 REMARK 470 LYS B 72 CD CE NZ REMARK 470 LYS B 76 CD CE NZ REMARK 470 LYS B 91 CE NZ REMARK 470 LYS B 99 CD CE NZ REMARK 470 LYS B 102 CG CD CE NZ REMARK 470 LYS B 112 CG CD CE NZ REMARK 470 LYS B 141 CE NZ REMARK 470 GLU B 167 C O CB CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 59 -171.35 66.77 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue YX4 A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue YX4 A 302 DBREF 7MCF A 44 168 UNP O60885 BRD4_HUMAN 44 168 DBREF 7MCF B 44 168 UNP O60885 BRD4_HUMAN 44 168 SEQADV 7MCF GLY A 41 UNP O60885 EXPRESSION TAG SEQADV 7MCF HIS A 42 UNP O60885 EXPRESSION TAG SEQADV 7MCF MET A 43 UNP O60885 EXPRESSION TAG SEQADV 7MCF GLY B 41 UNP O60885 EXPRESSION TAG SEQADV 7MCF HIS B 42 UNP O60885 EXPRESSION TAG SEQADV 7MCF MET B 43 UNP O60885 EXPRESSION TAG SEQRES 1 A 128 GLY HIS MET ASN PRO PRO PRO PRO GLU THR SER ASN PRO SEQRES 2 A 128 ASN LYS PRO LYS ARG GLN THR ASN GLN LEU GLN TYR LEU SEQRES 3 A 128 LEU ARG VAL VAL LEU LYS THR LEU TRP LYS HIS GLN PHE SEQRES 4 A 128 ALA TRP PRO PHE GLN GLN PRO VAL ASP ALA VAL LYS LEU SEQRES 5 A 128 ASN LEU PRO ASP TYR TYR LYS ILE ILE LYS THR PRO MET SEQRES 6 A 128 ASP MET GLY THR ILE LYS LYS ARG LEU GLU ASN ASN TYR SEQRES 7 A 128 TYR TRP ASN ALA GLN GLU CYS ILE GLN ASP PHE ASN THR SEQRES 8 A 128 MET PHE THR ASN CYS TYR ILE TYR ASN LYS PRO GLY ASP SEQRES 9 A 128 ASP ILE VAL LEU MET ALA GLU ALA LEU GLU LYS LEU PHE SEQRES 10 A 128 LEU GLN LYS ILE ASN GLU LEU PRO THR GLU GLU SEQRES 1 B 128 GLY HIS MET ASN PRO PRO PRO PRO GLU THR SER ASN PRO SEQRES 2 B 128 ASN LYS PRO LYS ARG GLN THR ASN GLN LEU GLN TYR LEU SEQRES 3 B 128 LEU ARG VAL VAL LEU LYS THR LEU TRP LYS HIS GLN PHE SEQRES 4 B 128 ALA TRP PRO PHE GLN GLN PRO VAL ASP ALA VAL LYS LEU SEQRES 5 B 128 ASN LEU PRO ASP TYR TYR LYS ILE ILE LYS THR PRO MET SEQRES 6 B 128 ASP MET GLY THR ILE LYS LYS ARG LEU GLU ASN ASN TYR SEQRES 7 B 128 TYR TRP ASN ALA GLN GLU CYS ILE GLN ASP PHE ASN THR SEQRES 8 B 128 MET PHE THR ASN CYS TYR ILE TYR ASN LYS PRO GLY ASP SEQRES 9 B 128 ASP ILE VAL LEU MET ALA GLU ALA LEU GLU LYS LEU PHE SEQRES 10 B 128 LEU GLN LYS ILE ASN GLU LEU PRO THR GLU GLU HET YX4 A 301 69 HET YX4 A 302 69 HETNAM YX4 2-{3-(1,4-DIMETHYL-1H-1,2,3-TRIAZOL-5-YL)-6-FLUORO-5- HETNAM 2 YX4 [(S)-(3-FLUOROPYRIDIN-2-YL)(OXAN-4-YL)METHYL]-5H- HETNAM 3 YX4 PYRIDO[3,2-B]INDOL-7-YL}PROPAN-2-OL FORMUL 3 YX4 2(C29 H30 F2 N6 O2) FORMUL 5 HOH *94(H2 O) HELIX 1 AA1 GLN A 59 VAL A 69 1 11 HELIX 2 AA2 VAL A 69 LYS A 76 1 8 HELIX 3 AA3 ALA A 80 GLN A 84 5 5 HELIX 4 AA4 ASP A 96 ILE A 101 1 6 HELIX 5 AA5 ASP A 106 ASN A 116 1 11 HELIX 6 AA6 ASN A 121 ASN A 140 1 20 HELIX 7 AA7 ASP A 144 ASN A 162 1 19 HELIX 8 AA8 ASN B 61 VAL B 69 1 9 HELIX 9 AA9 VAL B 69 LYS B 76 1 8 HELIX 10 AB1 HIS B 77 GLN B 84 5 8 HELIX 11 AB2 ASP B 88 ASN B 93 1 6 HELIX 12 AB3 ASP B 96 ILE B 101 1 6 HELIX 13 AB4 ASP B 106 ASN B 116 1 11 HELIX 14 AB5 ASN B 121 ASN B 140 1 20 HELIX 15 AB6 ASP B 144 ASN B 162 1 19 SITE 1 AC1 13 TRP A 81 PRO A 82 PHE A 83 LEU A 92 SITE 2 AC1 13 ASN A 140 ILE A 146 MET A 149 HOH A 401 SITE 3 AC1 13 HOH A 422 THR B 134 TYR B 137 ILE B 138 SITE 4 AC1 13 GLU B 154 SITE 1 AC2 15 ASN A 130 GLU A 154 LEU A 158 ILE A 161 SITE 2 AC2 15 HOH A 419 HOH A 434 TRP B 81 PRO B 82 SITE 3 AC2 15 PHE B 83 LEU B 92 LEU B 94 ASN B 140 SITE 4 AC2 15 ILE B 146 MET B 149 HOH B 404 CRYST1 87.912 89.356 36.554 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011375 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011191 0.000000 0.00000 SCALE3 0.000000 0.000000 0.027357 0.00000